| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 |
| Total Revenue | 316 | 294 | 401 |
| Cost of Revenue | 45 | 21 | 46 |
|
| Gross Profit | 271 | 273 | 355 |
|
| Operating Expenses |
| Research Development | 174 | 144 | 217 |
| Selling General and Administrative | 647 | 713 | 1,047 |
| Non Recurring |
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
|
|
| Operating Income or Loss | (550) | (584) | (909) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 213 | 465 | 428 |
| Earnings Before Interest And Taxes | (345) | (118) | (481) |
| Interest Expense |
-
|
-
|
-
|
| Income Before Tax | (345) | (118) | (481) |
| Income Tax Expense |
-
|
-
|
-
|
| Minority Interest | (8) | 1 |
-
|
| |
| Net Income From Continuing Ops | (345) | (118) | (481) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
|
|
| Net Income | (345) | (118) | (481) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | ($345) | ($118) | ($481) |
0.51% Nasdaq 
Income Statement
